Company logo

RVMD - Revolution Medicines, Inc.

NASDAQ -> Healthcare -> Biotechnology
Redwood City, United States
Type: Equity

RVMD price evolution
RVMD
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $699.18 $360.79 $382.92 $428.96
Short term investments $1156.81 $454.8 $529.16 $482.58
Net receivables $1.25 $0.31 $2.51 $4
Inventory
Total current assets $1879.28 $824.47 $922.09 $922.75
Long term investments
Property, plant & equipment $100.01 $73.41 $73.45 $72.84
Goodwill & intangible assets $72.35 $72.61 $72.88 $73.15
Total noncurrent assets $182.42 $159.76 $151.62 $150.5
Total investments $1156.81 $454.8 $529.16 $482.58
Total assets $2061.7 $984.23 $1073.71 $1073.25
Current liabilities
Accounts payable $61.79 $29.63 $29.78 $19.91
Deferred revenue $1.43
Short long term debt $7.37 $5.75 $5.72 $5.92
Total current liabilities $143.85 $85.54 $78.06 $54.63
Long term debt $80.58 $57.09 $57.54 $57.68
Total noncurrent liabilities $91.66 $61.23 $64.81 $66.39
Total debt $87.94 $62.85 $63.26 $63.6
Total liabilities $235.51 $146.77 $142.87 $121.03
Shareholders' equity
Retained earnings -$1137.71 -$976.17 -$867.74 -$769.44
Other shareholder equity $0.54 -$0.87 -$1.25 -$0.56
Total shareholder equity $1826.19 $837.46 $930.84 $952.22
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $699.18 $163.15 $110.23 $105.35
Short term investments $1156.81 $483.53 $468.56 $336.47
Net receivables $1.25 $4.67 $5.93 $6.39
Inventory
Total current assets $1879.28 $660.18 $589.77 $454.12
Long term investments
Property, plant & equipment $100.01 $73.74 $71.24 $36.34
Goodwill & intangible assets $72.35 $73.42 $74.48 $75.55
Total noncurrent assets $182.42 $151.75 $148.22 $113.28
Total investments $1156.81 $483.53 $468.56 $336.47
Total assets $2061.7 $811.93 $737.99 $567.4
Current liabilities
Accounts payable $61.79 $21.31 $14.06 $12.61
Deferred revenue $4.46 $18.93 $20.59
Short long term debt $7.37 $6.77 $6.21 $3.67
Total current liabilities $143.85 $61.98 $60.35 $47.18
Long term debt $80.58 $57.43 $60.42 $28.99
Total noncurrent liabilities $91.66 $64.76 $75.07 $45.55
Total debt $87.94 $64.2 $66.63 $32.66
Total liabilities $235.51 $126.74 $135.42 $92.72
Shareholders' equity
Retained earnings -$1137.71 -$701.34 -$452.64 -$265.55
Other shareholder equity $0.54 -$1.78 -$0.38 $0.12
Total shareholder equity $1826.19 $685.19 $602.57 $474.68
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $0.74 $3.82 $7.01
Cost of revenue
Gross Profit $0.74 $3.82 $7.01
Operating activities
Research & development $148.48 $107.73 $97.98 $68.95
Selling, general & administrative $32.24 $15.51 $14.64 $13.22
Total operating expenses $180.72 $123.25 $112.62 $82.17
Operating income -$179.98 -$123.25 -$108.8 -$75.16
Income from continuing operations
EBIT -$160.89 -$112.3 -$98.3 -$68.1
Income tax expense $0.34 -$3.87
Interest expense $0.3
Net income
Net income -$161.54 -$108.43 -$98.3 -$68.1
Income (for common shares) -$161.54 -$108.43 -$98.3 -$68.1
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $11.58 $35.38 $29.39 $42.98
Cost of revenue
Gross Profit $11.58 $35.38 $29.39 $42.98
Operating activities
Research & development $423.14 $253.07 $186.95 $132.25
Selling, general & administrative $75.62 $40.59 $30.45 $21.43
Total operating expenses $498.76 $293.66 $217.4 $153.68
Operating income -$487.19 -$258.28 -$188.01 -$110.7
Income from continuing operations
EBIT -$439.59 -$249.13 -$187.08 -$108.46
Income tax expense -$3.52 -$0.42 -$0.37
Interest expense $0.3 $0.01 $0.07
Net income
Net income -$436.37 -$248.71 -$187.09 -$108.16
Income (for common shares) -$436.37 -$248.71 -$187.09 -$110.38
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$161.54 -$108.43 -$98.3 -$68.1
Operating activities
Depreciation $2.86 $2.15 $1.77 $2.53
Business acquisitions & disposals
Stock-based compensation $25.43 $13.67 $12.98 $9.7
Total cash flows from operations -$120.56 -$100.5 -$67.12 -$62.39
Investing activities
Capital expenditures -$2.32 -$2.54 -$1.12 -$1.76
Investments -$378.08 $79.89 -$42.42 $5.75
Total cash flows from investing -$380.4 $77.35 -$43.54 $4
Financing activities
Dividends paid
Sale and purchase of stock $2.55 $1.01 $64.63 $324.2
Net borrowings
Total cash flows from financing $839.35 $1.01 $64.63 $324.2
Effect of exchange rate
Change in cash and equivalents $338.39 -$22.13 -$46.03 $265.81
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$436.37 -$248.71 -$187.09 -$108.16
Operating activities
Depreciation $9.31 $9.66 $7.33 $6.54
Business acquisitions & disposals
Stock-based compensation $61.77 $31.2 $20.72 $8.89
Total cash flows from operations -$350.57 -$224.4 -$147.18 -$100.06
Investing activities
Capital expenditures -$7.73 -$10.82 -$6.53 -$2.93
Investments -$334.87 -$13.3 -$135.59 -$231.3
Total cash flows from investing -$342.6 -$24.12 -$142.12 -$234.23
Financing activities
Dividends paid
Sale and purchase of stock $392.39 $301.39 $294.6 $422.78
Net borrowings
Total cash flows from financing $1229.2 $301.43 $294.18 $422.78
Effect of exchange rate
Change in cash and equivalents $536.03 $52.91 $4.88 $88.48
Fundamentals
Market cap $5.31B
Enterprise value $4.70B
Shares outstanding 164.67M
Revenue $11.58M
EBITDA -$430.28M
EBIT -$439.59M
Net Income -$436.37M
Revenue Q/Q -95.16%
Revenue Y/Y N/A
P/E ratio -12.16
EV/Sales 405.55
EV/EBITDA -10.91
EV/EBIT -10.68
P/S ratio 458.33
P/B ratio 2.91
Book/Share 11.09
Cash/Share 4.25
EPS -$2.65
ROA -33.61%
ROE -38.39%
Debt/Equity 0.13
Net debt/EBITDA 1.08
Current ratio 13.06
Quick ratio 13.06